How should dysuria in an adult male be evaluated and treated?

Evaluation and Management of Dysuria in Adult Males

In adult males presenting with dysuria, begin with a focused history targeting symptom onset, sexual activity, and urinary patterns, perform urinalysis with culture, and conduct a digital rectal examination to differentiate between urinary tract infection, sexually transmitted infection, prostatitis, and benign prostatic hyperplasia—the four most common causes requiring distinct treatment approaches.

Initial Diagnostic Workup

History Components

• Document symptom onset and duration: Acute onset (<12 hours) suggests acute bacterial prostatitis, while gradual progression over months indicates benign prostatic hyperplasia 1, 2
• Assess sexual history: In men under 35 years, sexually transmitted organisms (particularly Chlamydia trachomatis and Neisseria gonorrhoeae) are the predominant pathogens causing urethritis 3, 4
• Characterize associated symptoms: Frequency, urgency, hesitancy, weak stream, incomplete emptying, fever, perineal pain, and urethral discharge 5, 1, 6
• Review medication history: Anticholinergics, antihistamines, and decongestants can worsen urinary symptoms 1
• Identify red-flag symptoms: Hematuria, recurrent infections, neurological complaints, or acute urinary retention warrant immediate specialist referral 5, 1

Physical Examination

• Suprapubic palpation: Detect bladder distention indicating possible urinary retention 5, 1
• Digital rectal examination (DRE): A small, exquisitely tender prostate indicates acute bacterial prostatitis; an enlarged, non-tender prostate suggests benign prostatic hyperplasia; nodules or asymmetry raise concern for prostate cancer 5, 1, 2
• External genitalia inspection: Look for urethral discharge, meatal erythema, or skin lesions 6, 3
• Neurological assessment: Evaluate lower extremity function and perineal sensation to exclude neurogenic bladder 1

Laboratory Testing

• Urinalysis (dipstick and microscopy): Essential for all men with dysuria to detect infection, hematuria, proteinuria, or glucosuria 5, 1, 6
• Urine culture: Mandatory to guide antibiotic therapy, especially for recurrent or complicated infections; all UTIs in men are considered complicated 1, 6
• Urethral swab or first-void urine nucleic acid amplification testing (NAAT): Obtain in sexually active men under 35 years or those with urethral discharge to test for C. trachomatis and N. gonorrhoeae 3

Differential Diagnosis and Treatment by Etiology

Urinary Tract Infection (More Common in Men >35 Years)

• Clinical presentation: Dysuria with frequency, urgency, suprapubic discomfort; typically caused by coliform bacteria (E. coli) related to urinary stasis from prostatic hyperplasia 7, 4
• Treatment: Initiate empiric antibiotics based on local resistance patterns while awaiting culture results 1
• Follow-up: Re-evaluate if symptoms persist after 48-72 hours of appropriate therapy 6

Sexually Transmitted Urethritis (More Common in Men <35 Years)

• Clinical presentation: Urethral discharge, penile itching or tingling, dysuria without frequency or urgency 3
• Diagnosis: Urethral discharge on examination, positive leukocyte esterase on first-void urine, or ≥10 white blood cells per high-power field in urine sediment 3
• First-line empiric therapy: Combination of azithromycin or doxycycline plus ceftriaxone or cefixime to cover both C. trachomatis and N. gonorrhoeae 3
• Partner management: Expedited partner treatment is recommended; provide prescriptions for partners who have not been examined 3
• Persistent symptoms: If urethritis persists with negative initial testing, test for Mycoplasma genitalium 6, 3

Acute Bacterial Prostatitis

• Clinical presentation: Acute onset (<12 hours) of dysuria, frequency, urgency, perineal/pelvic pain, fever, and acute urinary retention 2
• Physical examination: Small, exquisitely tender prostate on DRE distinguishes this from benign prostatic hyperplasia 2
• Treatment: Requires prolonged antibiotic therapy (typically fluoroquinolones for 4-6 weeks) and may necessitate urinary catheterization if retention is present 2

Benign Prostatic Hyperplasia

• Clinical presentation: Gradual onset (months to years) of weak stream, hesitancy, intermittency, incomplete emptying, frequency, and nocturia 5, 1
• Physical examination: Enlarged, non-tender prostate on DRE 5, 2
• Symptom quantification: Use International Prostate Symptom Score (IPSS): 0-7 mild, 8-19 moderate, 20-35 severe 5, 1
• First-line pharmacologic therapy: Alpha-blockers (e.g., tamsulosin 0.4 mg daily) provide rapid relief within 2-4 weeks 1
• Assessment timing: Evaluate treatment response at 2-4 weeks for alpha-blockers and 3 months for 5α-reductase inhibitors 1

Additional Diagnostic Testing (Selective Use)

Post-Void Residual (PVR) Measurement

• Indications: Obstructive symptoms, suspected retention, before initiating anticholinergics, or when retention is suspected 5, 1
• Interpretation: PVR >100-200 mL is clinically significant and indicates incomplete bladder emptying 1

Uroflowmetry

• Utility: Provides objective assessment of voiding function; peak flow (Qmax) <10 mL/second indicates severe obstruction requiring urologic referral 5, 1

Prostate-Specific Antigen (PSA)

• Indications: Men ≥50 years with life expectancy >10 years when result could influence management; helps estimate prostate volume and screen for prostate cancer 5, 1, 8
• Counseling: Discuss implications of elevated PSA and false-positive risk before testing 5

Cystourethroscopy

• Indications: Suspected urethral stricture (history of catheterization, trauma, sexually transmitted infections, split stream), hematuria, or recurrent infections 5, 1

Immediate Urologic Referral Criteria

Refer immediately before initiating treatment if any of the following are present:

• Neurological disease affecting bladder function 1
• Severe obstruction (Qmax <10 mL/second) 1
• Hematuria (microscopic or gross) 1, 8
• Abnormal DRE findings suspicious for prostate cancer 1, 8
• Recurrent urinary tract infections (≥2 episodes in 6 months or ≥3 in 12 months) 1, 8
• Palpable bladder or PVR >200-300 mL 1, 8
• Acute urinary retention 8

Common Pitfalls to Avoid

• Do not empirically treat with antibiotics without urinalysis and culture: Overtreatment of asymptomatic bacteriuria is common and provides no benefit while promoting antimicrobial resistance 5
• Do not assume all dysuria in young men is UTI: Sexually transmitted urethritis is more common in this age group and requires different treatment 3, 4
• Do not overlook acute bacterial prostatitis: The acute onset (<12 hours) and tender prostate distinguish this from chronic conditions requiring gradual evaluation 2
• Do not start anticholinergics without measuring PVR: Risk of precipitating acute urinary retention in men with elevated residual volumes 1
• Do not ignore hematuria: Requires aggressive workup including cystoscopy and upper tract imaging regardless of other findings 1, 8

Follow-Up Strategy

• Initial follow-up: Schedule at 4-12 weeks after treatment initiation to assess efficacy and adverse effects 1
• Persistent symptoms: If dysuria persists after initial evaluation and treatment, expand workup to include cystoscopy, imaging, and consideration of non-infectious causes such as urethral stricture, interstitial cystitis, or genitourinary malignancy 6, 7
• Annual surveillance: For patients with successful treatment of benign prostatic hyperplasia to detect symptom progression or complications 1